Fulgent Genetics Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 4/6
Fulgent Genetics hat ein Gesamteigenkapital von $1.1B und eine Gesamtverschuldung von $2.9M, was einen Verschuldungsgrad von 0.3% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen $1.2B bzw. $98.9M.
Wichtige Informationen
0.3%
Verhältnis von Schulden zu Eigenkapital
US$2.91m
Verschuldung
| Zinsdeckungsgrad | n/a |
| Bargeld | US$213.07m |
| Eigenkapital | US$1.13b |
| Gesamtverbindlichkeiten | US$98.87m |
| Gesamtvermögen | US$1.23b |
Jüngste Berichte zur Finanzlage
Is Fulgent Genetics (NASDAQ:FLGT) Using Debt Sensibly?
Dec 14
Fulgent Genetics (NASDAQ:FLGT) Has Debt But No Earnings; Should You Worry?
Aug 09Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet?
Dec 28Fulgent Genetics (NASDAQ:FLGT) Seems To Use Debt Rather Sparingly
Sep 05These 4 Measures Indicate That Fulgent Genetics (NASDAQ:FLGT) Is Using Debt Safely
May 04Recent updates
Fulgent Genetics: An NCAV Pick With Profit And Growth Potential
Sep 25Fulgent Genetics: Core Growth Re-Acceleration Will Be The Critical Catalyst
Sep 09Some Shareholders Feeling Restless Over Fulgent Genetics, Inc.'s (NASDAQ:FLGT) P/S Ratio
Jul 17Fulgent Genetics: Growth Is Returning
Jun 06Shareholders May Be Wary Of Increasing Fulgent Genetics, Inc.'s (NASDAQ:FLGT) CEO Compensation Package
May 10Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report
May 07Are Investors Undervaluing Fulgent Genetics, Inc. (NASDAQ:FLGT) By 32%?
Mar 01Fulgent Genetics: Buy Growth Ahead Below Liquidation Value
Feb 21Subdued Growth No Barrier To Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Price
Jan 17Is Fulgent Genetics (NASDAQ:FLGT) Using Debt Sensibly?
Dec 14Fulgent Genetics (NASDAQ:FLGT) Has Debt But No Earnings; Should You Worry?
Aug 09Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report
May 09Fulgent Genetics (NASDAQ:FLGT) Is Looking To Continue Growing Its Returns On Capital
Apr 19Why We Like The Returns At Fulgent Genetics (NASDAQ:FLGT)
Jan 15Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet?
Dec 28What Does The Future Hold For Fulgent Genetics, Inc. (NASDAQ:FLGT)? These Analysts Have Been Cutting Their Estimates
Nov 16Why Fulgent Genetics, Inc. (NASDAQ:FLGT) Could Be Worth Watching
Oct 27Wait For Fulgent Genetics To Grow Up
Oct 13We Like Fulgent Genetics' (NASDAQ:FLGT) Returns And Here's How They're Trending
Sep 19Fulgent Genetics (NASDAQ:FLGT) Seems To Use Debt Rather Sparingly
Sep 05Fulgent Genetics: Poised To Survive Its Post-Covid Hangover
Jul 26Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Low P/E No Reason For Excitement
Jul 21Fulgent Genetics (NASDAQ:FLGT) Is Investing Its Capital With Increasing Efficiency
Jun 04Fulgent Is Putting Its Cash Bonanza To Work
May 15These 4 Measures Indicate That Fulgent Genetics (NASDAQ:FLGT) Is Using Debt Safely
May 04Fulgent Genetics: Now The Going Could Get Much Tougher
Apr 10Fulgent Genetics: COVID Bolstered The Underlying Business
Mar 17Fulgent Genetics: Somewhat Disappoints With A Marked Slowdown In Its NGS Business
Feb 27Fulgent Genetics Stock: 35% Off Its Recent Highs - It Is Now A Buy
Feb 09Fulgent Genetics: Sell Volatility
Jan 26Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: FLGTDie kurzfristigen Aktiva des Unternehmens ($326.5M) übersteigen seine kurzfristigen Passiva ($74.0M).
Langfristige Verbindlichkeiten: FLGTDie kurzfristigen Vermögenswerte des Unternehmens ($326.5M) übersteigen seine langfristigen Verbindlichkeiten ($24.9M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: FLGT über mehr Barmittel verfügt als seine Gesamtverschuldung.
Schulden abbauen: FLGTDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 0% auf 0.3% gestiegen.
Schuldendeckung: FLGTDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (377.8%).
Zinsdeckung: Unzureichende Daten, um zu bestimmen, ob die Zinszahlungen von FLGT für seine Schulden durch das EBIT gut gedeckt sind.